Atlas Trials

ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen

Clinical trial NCT00003034 · UNKNOWN

Trial details

NCT number
NCT00003034
Sponsor
Alfacell
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Malignant Mesothelioma
Start date
1997-05-01
Primary completion
2008-02-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.